Sun Pharma Advanced Research Balance Sheet Health
Financial Health criteria checks 5/6
Sun Pharma Advanced Research has a total shareholder equity of ₹3.3B and total debt of ₹142.1M, which brings its debt-to-equity ratio to 4.3%. Its total assets and total liabilities are ₹6.7B and ₹3.4B respectively.
Key information
4.3%
Debt to equity ratio
₹142.10m
Debt
Interest coverage ratio | n/a |
Cash | ₹3.66b |
Equity | ₹3.32b |
Total liabilities | ₹3.36b |
Total assets | ₹6.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532872's short term assets (₹4.4B) exceed its short term liabilities (₹2.1B).
Long Term Liabilities: 532872's short term assets (₹4.4B) exceed its long term liabilities (₹1.2B).
Debt to Equity History and Analysis
Debt Level: 532872 has more cash than its total debt.
Reducing Debt: 532872's debt to equity ratio has increased from 0.5% to 4.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 532872 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 532872 has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 5.4% each year.